They observed that patients with SSc exhibited higher levels of TSH, more cases of hypothyroidism (both clinical and subclinical), and higher levels and prevalence of anti-TPO and anti-thyroglobulin (anti-Tg) antibodies in comparison to control patients, the difference reaching statistical significance. The gene discussed is TPO; the disease is systemic sclerosis.